| 1 | Journal of Cell Science | 1.59 | Q2 | 325 | 2.82 | United Kingdom | 非OA | Company of Biologists |
| 2 | Extracellular Vesicles and Circulating Nucleic Acids | 1.44 | Q2 | 20 | 6.51 | United States | 非OA | OAE Publishing Inc. |
| 3 | Molecular Biology of the Cell | 1.44 | Q2 | 256 | 2.68 | United States | 非OA | American Society for C |
| 4 | Mobile DNA | 1.42 | Q2 | 52 | 4.38 | United Kingdom | 完全OA | BioMed Central Ltd |
| 5 | Frontiers in Molecular Neuroscience | 1.41 | Q2 | 119 | 3.91 | Switzerland | 完全OA | Frontiers Media SA |
| 6 | Neurochemistry International | 1.34 | Q2 | 145 | 5.67 | United Kingdom | 非OA | Elsevier Ltd |
| 7 | Endocrinology (United States) | 1.30 | Q2 | 296 | 3.21 | United States | 非OA | Endocrine Society |
| 8 | Cellular Signalling | 1.29 | Q2 | 176 | 4.76 | United States | 非OA | Elsevier Inc. |
| 9 | Journal of Endocrinological Investigation | 1.25 | Q2 | 108 | 4.23 | Switzerland | 非OA | Springer Science and B |
| 10 | Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids | 1.25 | Q2 | 191 | 3.85 | Netherlands | 非OA | Elsevier B.V. |
| 11 | Journal of Extracellular Biology | 1.24 | Q2 | 16 | 4.53 | United States | 完全OA | John Wiley and Sons In |
| 12 | Molecular Brain | 1.24 | Q2 | 88 | 3.74 | United Kingdom | 完全OA | BioMed Central Ltd |
| 13 | Mediators of Inflammation | 1.24 | Q2 | 154 | 5.10 | United Kingdom | 完全OA | John Wiley and Sons Lt |
| 14 | Stem Cell Reviews and Reports | 1.22 | Q2 | 96 | 4.47 | United States | 非OA | Springer |
| 15 | Journal of Leukocyte Biology | 1.20 | Q2 | 231 | 3.18 | United States | 非OA | Oxford University Pres |
| 16 | American Journal of Medical Genetics, Part C: Seminars in Medical Genetics | 1.20 | Q2 | 122 | 1.93 | United States | 非OA | Wiley-Liss Inc. |
| 17 | Chromosome Research | 1.20 | Q2 | 92 | 2.78 | Netherlands | 非OA | — |
| 18 | Cell Adhesion and Migration | 1.19 | Q2 | 84 | 4.15 | United States | 完全OA | Taylor and Francis Ltd |
| 19 | Journal of Molecular Endocrinology | 1.18 | Q2 | 118 | 3.03 | United Kingdom | 非OA | BioScientifica Ltd. |
| 20 | BMC Cancer | 1.17 | Q2 | 180 | 4.05 | United Kingdom | 完全OA | BioMed Central Ltd |
| 21 | Current Research in Structural Biology | 1.16 | Q2 | 20 | 4.32 | Netherlands | 完全OA | Elsevier B.V. |
| 22 | Pituitary | 1.16 | Q2 | 88 | 2.89 | United States | 非OA | Springer |
| 23 | Differentiation | 1.14 | Q2 | 111 | 3.68 | United Kingdom | 非OA | Elsevier Ltd |
| 24 | Journal of Cellular and Molecular Medicine | 1.14 | Q2 | 172 | 4.40 | United States | 完全OA | John Wiley and Sons In |
| 25 | Probiotics and Antimicrobial Proteins | 1.14 | Q2 | 73 | 7.17 | United States | 非OA | Springer |
| 26 | Journal of General Physiology | 1.13 | Q2 | 145 | 2.23 | United States | 非OA | Rockefeller University |
| 27 | Molecular and Cellular Neuroscience | 1.12 | Q2 | 154 | 3.28 | United States | 非OA | Academic Press Inc. |
| 28 | Aging | 1.11 | Q2 | 144 | 3.56 | United States | 完全OA | Impact Journals LLC |
| 29 | Gerontology | 1.10 | Q2 | 124 | 3.08 | Switzerland | 非OA | S. Karger AG |
| 30 | JCO Global Oncology | 1.10 | Q2 | 50 | 2.90 | United States | 完全OA | Lippincott Williams an |
| 31 | Oncology Reviews | 1.10 | Q2 | 35 | 3.86 | Switzerland | 完全OA | Frontiers Media SA |
| 32 | Proteins: Structure, Function and Genetics | 1.10 | Q2 | 214 | 3.30 | United States | 非OA | — |
| 33 | Immunology and Cell Biology | 1.08 | Q2 | 126 | 2.32 | United States | 非OA | John Wiley & Sons |
| 34 | Biochemistry | 1.06 | Q2 | 289 | 2.64 | United States | 非OA | American Chemical Soci |
| 35 | Frontiers in Physiology | 1.06 | Q2 | 195 | 3.96 | Switzerland | 完全OA | Frontiers Media SA |
| 36 | Journal of Clinical and Translational Endocrinology | 1.06 | Q2 | 36 | 4.48 | Netherlands | 完全OA | Elsevier B.V. |
| 37 | Cells and Development | 1.06 | Q2 | 154 | 2.29 | Netherlands | 非OA | Elsevier B.V. |
| 38 | Plasmid | 1.06 | Q2 | 71 | 2.26 | United States | 非OA | Academic Press Inc. |
| 39 | Journal of Diabetes and its Complications | 1.06 | Q2 | 108 | 3.10 | United States | 非OA | Elsevier Inc. |
| 40 | Endocrine Connections | 1.05 | Q2 | 57 | 3.36 | United Kingdom | 完全OA | BioScientifica Ltd. |
| 41 | Molecular Carcinogenesis | 1.05 | Q2 | 114 | 3.54 | United States | 非OA | Wiley-Liss Inc. |
| 42 | Clinical Proteomics | 1.04 | Q2 | 49 | 4.22 | United Kingdom | 完全OA | BioMed Central Ltd |
| 43 | Developmental Biology | 1.04 | Q2 | 257 | 2.01 | United States | 非OA | Elsevier Inc. |
| 44 | Journal of Diabetes Research | 1.04 | Q2 | 99 | 3.68 | United Kingdom | 完全OA | John Wiley and Sons Lt |
| 45 | Cancer Epidemiology | 1.04 | Q2 | 94 | 3.14 | United Kingdom | 非OA | Elsevier Ltd |
| 46 | Alkaloids: Chemistry and Biology | 1.03 | Q2 | 52 | 1.58 | United States | 非OA | Academic Press Inc. |
| 47 | Journal of Neuro-Oncology | 1.03 | Q2 | 147 | 3.24 | United States | 非OA | Springer |
| 48 | Metabolites | 1.03 | Q2 | 97 | 4.84 | Switzerland | 完全OA | Multidisciplinary Digi |
| 49 | Frontiers in Oncology | 1.02 | Q2 | 173 | 3.14 | Switzerland | 完全OA | Frontiers Media SA |
| 50 | JRAAS - Journal of the Renin-Angiotensin-Aldosterone System | 1.02 | Q2 | 54 | 6.86 | United Kingdom | 完全OA | SAGE Publications Ltd |
| 51 | Current Opinion in Physiology | 1.02 | Q2 | 39 | 2.03 | United Kingdom | 非OA | Elsevier Ltd |
| 52 | Experimental Cell Research | 1.01 | Q2 | 213 | 3.94 | United States | 非OA | Elsevier Inc. |
| 53 | Stem Cells International | 1.01 | Q2 | 110 | 4.01 | United Kingdom | 完全OA | John Wiley and Sons Lt |
| 54 | Peptides | 1.01 | Q2 | 148 | 3.23 | United States | 非OA | Elsevier Inc. |
| 55 | Cancer Treatment and Research Communications | 0.99 | Q2 | 35 | 3.49 | United Kingdom | 完全OA | Elsevier Ltd |
| 56 | Metabolic Brain Disease | 0.99 | Q2 | 87 | 4.18 | United States | 非OA | Springer |
| 57 | Vascular Pharmacology | 0.99 | Q2 | 114 | 3.23 | United States | 非OA | Elsevier Inc. |
| 58 | Journal of Structural Biology | 0.98 | Q2 | 171 | 2.46 | United States | 非OA | Academic Press Inc. |
| 59 | Molecular and Cellular Biology | 0.98 | Q2 | 367 | 2.37 | United States | 非OA | Taylor and Francis Ltd |
| 60 | Cancer Cytopathology | 0.98 | Q2 | 78 | 2.13 | United States | 非OA | John Wiley and Sons In |
| 61 | Endocrine | 0.98 | Q2 | 111 | 3.55 | United States | 非OA | Springer |
| 62 | Heredity | 0.98 | Q2 | 146 | 2.57 | Switzerland | 完全OA | Springer Nature |
| 63 | Journal of Physiological Sciences | 0.98 | Q2 | 65 | 3.13 | United States | 完全OA | Elsevier Inc. |
| 64 | Cancer Causes and Control | 0.98 | Q2 | 153 | 2.55 | Germany | 非OA | Springer Science and B |
| 65 | Clinical Genetics | 0.98 | Q2 | 125 | 2.39 | United Kingdom | 非OA | Wiley-Blackwell Publis |
| 66 | Current Opinion in Oncology | 0.98 | Q2 | 108 | 2.43 | United States | 非OA | Lippincott Williams an |
| 67 | NeuroMolecular Medicine | 0.98 | Q2 | 89 | 3.63 | United States | 非OA | Springer |
| 68 | Clinical Endocrinology | 0.98 | Q2 | 176 | 2.61 | United Kingdom | 非OA | Wiley-Blackwell Publis |
| 69 | Genes and Nutrition | 0.98 | Q2 | 72 | 2.81 | United Kingdom | 完全OA | BioMed Central Ltd |
| 70 | Biomolecules and Therapeutics | 0.97 | Q2 | 66 | 4.78 | South Korea | 非OA | Korean Society of Appl |
| 71 | Molecular Immunology | 0.97 | Q2 | 160 | 3.56 | United Kingdom | 非OA | Elsevier Ltd |
| 72 | Proteomes | 0.97 | Q2 | 40 | 4.87 | Switzerland | 完全OA | Multidisciplinary Digi |
| 73 | Advances in Redox Research | 0.96 | Q2 | 15 | 4.39 | United States | 完全OA | Elsevier Inc. |
| 74 | Experimental Hematology | 0.96 | Q2 | 133 | 2.34 | United States | 非OA | Elsevier Inc. |
| 75 | Journal of Heredity | 0.95 | Q2 | 108 | 2.30 | United Kingdom | 非OA | Oxford University Pres |
| 76 | Neuroendocrinology | 0.95 | Q2 | 119 | 2.81 | Switzerland | 非OA | S. Karger AG |
| 77 | Experimental Physiology | 0.95 | Q2 | 123 | 2.86 | United Kingdom | 完全OA | John Wiley and Sons In |
| 78 | Best Practice and Research: Clinical Haematology | 0.94 | Q2 | 84 | 2.93 | United Kingdom | 非OA | Bailliere Tindall Ltd |
| 79 | International Journal of Biochemistry and Cell Biology | 0.94 | Q2 | 219 | 3.60 | United Kingdom | 非OA | Elsevier Ltd |
| 80 | Metabolomics | 0.94 | Q2 | 107 | 3.46 | United States | 非OA | Springer |
| 81 | AIDS Research and Therapy | 0.93 | Q2 | 54 | 2.62 | United Kingdom | 完全OA | BioMed Central Ltd |
| 82 | Biological Procedures Online | 0.93 | Q2 | 56 | 4.51 | United Kingdom | 完全OA | BioMed Central Ltd |
| 83 | Molecular Medicine Reports | 0.93 | Q2 | 106 | 4.04 | Greece | 非OA | Spandidos Publications |
| 84 | Clinical Breast Cancer | 0.93 | Q2 | 88 | 2.72 | United States | 非OA | Elsevier Inc. |
| 85 | Innate Immunity | 0.93 | Q2 | 84 | 3.77 | United Kingdom | 完全OA | SAGE Publications Ltd |
| 86 | Journal of Human Genetics | 0.92 | Q2 | 100 | 2.97 | United Kingdom | 非OA | Springer Nature |
| 87 | Journal of Pharmacology and Experimental Therapeutics | 0.92 | Q2 | 254 | 3.40 | United States | 非OA | Elsevier Inc. |
| 88 | Infectious Agents and Cancer | 0.92 | Q2 | 54 | 3.17 | United Kingdom | 完全OA | BioMed Central Ltd |
| 89 | Digestive Diseases and Sciences | 0.92 | Q2 | 152 | 2.15 | United States | 非OA | Springer |
| 90 | FEBS Open Bio | 0.92 | Q2 | 58 | 2.72 | United States | 完全OA | John Wiley and Sons In |
| 91 | Nutrition Research | 0.92 | Q2 | 124 | 3.70 | United States | 非OA | Elsevier Inc. |
| 92 | Journal of Cellular Biochemistry | 0.91 | Q2 | 195 | 3.19 | United States | 非OA | Wiley-Liss Inc. |
| 93 | Cardiovascular Toxicology | 0.90 | Q2 | 70 | 3.53 | United States | 非OA | Springer |
| 94 | American Journal of Physiology - Regulatory Integrative and Comparative Physiology | 0.90 | Q2 | 206 | 2.67 | United States | 完全OA | American Physiological |
| 95 | Current Issues in Molecular Biology | 0.90 | Q2 | 72 | 4.27 | Switzerland | 完全OA | Multidisciplinary Digi |
| 96 | Advances in Biological Regulation | 0.89 | Q2 | 75 | 2.45 | United Kingdom | 非OA | Elsevier Ltd |
| 97 | Brain Research | 0.89 | Q2 | 268 | 3.39 | Netherlands | 非OA | Elsevier B.V. |
| 98 | G3: Genes, Genomes, Genetics | 0.89 | Q2 | 98 | 2.46 | United States | 完全OA | Genetics Society of Am |
| 99 | Journal of Pharmacological Sciences | 0.89 | Q2 | 106 | 3.05 | Japan | 完全OA | Japanese Pharmacologic |
| 100 | Journal of Breast Cancer | 0.89 | Q2 | 55 | 3.87 | South Korea | 完全OA | Korean Breast Cancer S |
| 101 | Oncology Reports | 0.89 | Q2 | 125 | 3.48 | Greece | 非OA | Spandidos Publications |
| 102 | International Journal of Aging and Human Development | 0.89 | Q2 | 76 | 3.03 | United States | 非OA | SAGE Publications Inc. |
| 103 | Non-coding RNA | 0.89 | Q2 | 48 | 4.01 | Switzerland | 完全OA | Multidisciplinary Digi |
| 104 | World Journal of Stem Cells | 0.88 | Q2 | 48 | 4.47 | United States | 完全OA | Baishideng Publishing |
| 105 | Exploration of Targeted Anti-tumor Therapy | 0.88 | Q2 | 21 | 3.77 | China | 完全OA | Open Exploration Publi |
| 106 | Physiological Genomics | 0.88 | Q2 | 132 | 2.62 | United States | 非OA | American Physiological |
| 107 | Current Research in Translational Medicine | 0.88 | Q2 | 72 | 2.74 | France | 非OA | Elsevier Masson s.r.l. |
| 108 | Hormones and Behavior | 0.88 | Q2 | 171 | 2.59 | United States | 非OA | Academic Press Inc. |
| 109 | Leukemia Research | 0.88 | Q2 | 100 | 1.92 | United Kingdom | 非OA | Elsevier Ltd |
| 110 | BMC Biotechnology | 0.88 | Q2 | 105 | 4.99 | United Kingdom | 完全OA | BioMed Central Ltd |
| 111 | Journal of Developmental Biology | 0.88 | Q2 | 33 | 2.49 | Switzerland | 完全OA | Multidisciplinary Digi |
| 112 | Molecular Reproduction and Development | 0.88 | Q2 | 121 | 3.42 | United States | 非OA | Wiley-Liss Inc. |
| 113 | Journal of Industrial Microbiology and Biotechnology | 0.87 | Q2 | 144 | 4.31 | United Kingdom | 完全OA | Oxford University Pres |
| 114 | Nitric Oxide - Biology and Chemistry | 0.87 | Q2 | 116 | 4.46 | United States | 非OA | Academic Press Inc. |
| 115 | Genomics | 0.87 | Q2 | 164 | 3.54 | United States | 完全OA | Academic Press Inc. |
| 116 | Aging and Cancer | 0.87 | Q2 | 11 | 1.93 | United States | 完全OA | John Wiley and Sons In |
| 117 | Genesis (United States) | 0.87 | Q2 | 128 | 1.44 | United States | 非OA | Wiley-Liss Inc. |
| 118 | Cancer Journal (United States) | 0.87 | Q2 | 110 | 1.93 | United States | 非OA | Lippincott Williams an |
| 119 | Purinergic Signalling | 0.86 | Q2 | 73 | 2.60 | Netherlands | 非OA | Springer Science and B |
| 120 | Leukemia and Lymphoma | 0.86 | Q2 | 109 | 1.64 | United Kingdom | 非OA | Taylor and Francis Ltd |
| 121 | International Journal of Stem Cells | 0.85 | Q2 | 39 | 2.61 | South Korea | 非OA | Sungkyunkwan Universit |
| 122 | Addiction Neuroscience | 0.85 | Q2 | 14 | 2.28 | United States | 完全OA | Elsevier Inc. |
| 123 | Human Cell | 0.85 | Q2 | 52 | 3.01 | Japan | 非OA | Springer |
| 124 | Blood Cells, Molecules, and Diseases | 0.85 | Q2 | 105 | 2.11 | United States | 非OA | Academic Press Inc. |
| 125 | Cancer Chemotherapy and Pharmacology | 0.85 | Q2 | 132 | 2.44 | Germany | 完全OA | Springer Science and B |
| 126 | Interdisciplinary Sciences - Computational Life Sciences | 0.85 | Q2 | 43 | 6.15 | Germany | 非OA | Springer Science and B |
| 127 | Familial Cancer | 0.85 | Q2 | 72 | 2.19 | Netherlands | 非OA | Springer Science and B |
| 128 | Biomolecules and Biomedicine | 0.85 | Q2 | 50 | 3.37 | Bosnia and Herzegovina | 完全OA | Association of Basic M |
| 129 | Diagnostics | 0.85 | Q2 | 103 | 4.36 | Switzerland | 完全OA | Multidisciplinary Digi |
| 130 | STAR Protocols | 0.85 | Q2 | 34 | 1.41 | United States | 完全OA | Cell Press |
| 131 | Glycobiology | 0.84 | Q2 | 150 | 2.88 | United Kingdom | 非OA | Oxford University Pres |
| 132 | Annales d'Endocrinologie | 0.84 | Q2 | 53 | 2.33 | France | 非OA | Elsevier Masson s.r.l. |
| 133 | GigaByte | 0.84 | Q2 | 14 | 1.46 | China | 完全OA | GigaScience Press |
| 134 | Biotechnology Notes | 0.84 | Q2 | 13 | 7.05 | China | 非OA | KeAi Communications Co |
| 135 | Developmental Dynamics | 0.84 | Q2 | 161 | 1.59 | United States | 非OA | Wiley-Liss Inc. |
| 136 | Regenerative Therapy | 0.84 | Q2 | 42 | 4.25 | Japan | 完全OA | Japanese Society of Re |
| 137 | Clinical and Translational Oncology | 0.83 | Q2 | 69 | 2.81 | Germany | 非OA | Springer Science and B |
| 138 | Frontiers in Genetics | 0.83 | Q2 | 147 | 2.88 | Switzerland | 完全OA | Frontiers Media SA |
| 139 | IEEE Transactions on Computational Biology and Bioinformatics | 0.83 | Q2 | 102 | 4.62 | United States | 非OA | Institute of Electrica |
| 140 | Journal of Liquid Biopsy | 0.83 | Q2 | 9 | 4.58 | Netherlands | 完全OA | Elsevier B.V. |
| 141 | Prostaglandins Leukotrienes and Essential Fatty Acids | 0.83 | Q2 | 125 | 2.49 | United Kingdom | 非OA | Churchill Livingstone |
| 142 | Advanced Sensor Research | 0.83 | Q2 | 21 | 5.16 | Germany | 完全OA | Wiley-VCH Verlag |
| 143 | Cell Biochemistry and Function | 0.83 | Q2 | 79 | 3.68 | United Kingdom | 非OA | John Wiley and Sons Lt |
| 144 | Virus Research | 0.83 | Q2 | 158 | 3.51 | Netherlands | 完全OA | Elsevier B.V. |
| 145 | Journal of Neurophysiology | 0.83 | Q2 | 279 | 2.16 | United States | 非OA | American Physiological |
| 146 | Translational Medicine of Aging | 0.83 | Q2 | 15 | 2.48 | China | 完全OA | KeAi Communications Co |
| 147 | Discover Mental Health | 0.83 | Q2 | 11 | 2.59 | Switzerland | 完全OA | Springer Nature |
| 148 | Genes | 0.82 | Q2 | 119 | 3.32 | Switzerland | 完全OA | Multidisciplinary Digi |
| 149 | Genetics in Medicine Open | 0.82 | Q2 | 10 | 2.25 | Netherlands | 完全OA | Elsevier B.V. |
| 150 | European Journal of Medical Genetics | 0.82 | Q2 | 71 | 2.39 | France | 非OA | Elsevier Masson s.r.l. |
| 151 | Mammalian Genome | 0.82 | Q2 | 109 | 2.39 | United States | 非OA | Springer |
| 152 | Methods | 0.82 | Q2 | 183 | 3.51 | United States | 非OA | Academic Press Inc. |
| 153 | Breast Cancer: Basic and Clinical Research | 0.82 | Q2 | 40 | 2.10 | United Kingdom | 完全OA | SAGE Publications Ltd |
| 154 | Organoids | 0.81 | Q2 | 10 | 2.59 | Switzerland | 完全OA | Multidisciplinary Digi |
| 155 | ChemSystemsChem | 0.81 | Q2 | 21 | 2.12 | Germany | 非OA | John Wiley and Sons In |
| 156 | Current Problems in Cancer | 0.81 | Q2 | 54 | 2.79 | United States | 非OA | Elsevier Inc. |
| 157 | Aging Medicine | 0.81 | Q2 | 25 | 2.75 | United States | 完全OA | John Wiley and Sons In |
| 158 | Cancer Genomics and Proteomics | 0.81 | Q2 | 53 | 2.66 | Greece | 非OA | International Institut |
| 159 | Journal of Biochemistry | 0.81 | Q2 | 134 | 2.26 | United Kingdom | 完全OA | Oxford University Pres |
| 160 | Briefings in Functional Genomics | 0.81 | Q2 | 91 | 3.34 | United Kingdom | 非OA | Oxford University Pres |
| 161 | Biosensors and Bioelectronics: X | 0.81 | Q2 | 37 | 6.19 | United Kingdom | 完全OA | Elsevier Ltd |
| 162 | Immunogenetics | 0.80 | Q2 | 104 | 2.14 | Germany | 非OA | Springer Science and B |
| 163 | Tumor Biology | 0.80 | Q2 | 111 | 3.05 | United Kingdom | 完全OA | SAGE Publications Ltd |
| 164 | Journal of Biochemical and Molecular Toxicology | 0.80 | Q2 | 78 | 3.89 | United States | 非OA | John Wiley & Sons |
| 165 | NeuroImmunoModulation | 0.80 | Q2 | 78 | 3.36 | Switzerland | 完全OA | S. Karger AG |
| 166 | Journal of Bone and Mineral Metabolism | 0.80 | Q2 | 91 | 2.49 | Japan | 非OA | Springer |
| 167 | Transfusion Medicine Reviews | 0.80 | Q2 | 92 | 2.63 | United States | 非OA | W.B. Saunders |
| 168 | JMIR Cancer | 0.80 | Q2 | 31 | 3.12 | Canada | 完全OA | JMIR Publications Inc. |
| 169 | AMB Express | 0.80 | Q2 | 80 | 3.91 | Germany | 完全OA | Springer Science and B |
| 170 | Biomarkers in Neuropsychiatry | 0.80 | Q2 | 17 | 2.88 | Netherlands | 完全OA | Elsevier B.V. |
| 171 | Frontiers in Drug Delivery | 0.79 | Q2 | 13 | 4.48 | Switzerland | 完全OA | Frontiers Media SA |
| 172 | Journal of Bioenergetics and Biomembranes | 0.79 | Q2 | 111 | 3.90 | United States | 非OA | Springer |
| 173 | Journal of Biomedical Research | 0.79 | Q2 | 50 | 2.78 | China | 非OA | Nanjing Medical Univer |
| 174 | Neuropeptides | 0.79 | Q2 | 83 | 3.20 | United Kingdom | 非OA | Churchill Livingstone |
| 175 | Magnetic Resonance Materials in Physics, Biology and Medicine | 0.78 | Q2 | 72 | 2.99 | Germany | 非OA | Springer Science and B |
| 176 | Quarterly Journal of Experimental Psychology | 0.78 | Q2 | 137 | 1.95 | United Kingdom | 非OA | SAGE Publications Inc. |
| 177 | Journal of Applied Microbiology | 0.78 | Q2 | 203 | 3.03 | United Kingdom | 非OA | Oxford University Pres |
| 178 | Frontiers in Bioscience - Elite | 0.78 | Q2 | 64 | 5.22 | United States | 完全OA | IMR Press Limited |
| 179 | Biochemistry and Biophysics Reports | 0.78 | Q2 | 56 | 3.46 | Netherlands | 完全OA | Elsevier B.V. |
| 180 | FASEB BioAdvances | 0.78 | Q2 | 26 | 2.31 | United Kingdom | 完全OA | John Wiley and Sons In |
| 181 | IRBM | 0.78 | Q2 | 54 | 2.23 | France | 非OA | Elsevier Masson s.r.l. |
| 182 | Epigenomics | 0.77 | Q2 | 85 | 2.51 | United Kingdom | 非OA | Taylor and Francis Ltd |
| 183 | Microvascular Research | 0.77 | Q2 | 105 | 3.13 | United States | 非OA | Academic Press Inc. |
| 184 | Expert Review of Proteomics | 0.77 | Q2 | 77 | 2.51 | United Kingdom | 非OA | Taylor and Francis Ltd |
| 185 | Endocrine Journal | 0.77 | Q2 | 91 | 2.01 | Japan | 完全OA | Japan Endocrine Societ |
| 186 | Journal of Materials Science: Materials in Medicine | 0.77 | Q2 | 154 | 4.77 | United States | 完全OA | Springer |
| 187 | Physiological Research | 0.77 | Q2 | 89 | 2.79 | Czech Republic | 完全OA | Czech Academy of Scien |
| 188 | Journal of Biotechnology | 0.77 | Q2 | 188 | 4.58 | Netherlands | 非OA | Elsevier B.V. |
| 189 | Journal of Membrane Science Letters | 0.77 | Q2 | 19 | 4.82 | Netherlands | 完全OA | Elsevier B.V. |
| 190 | Archives of Physiology and Biochemistry | 0.76 | Q2 | 64 | 3.72 | United Kingdom | 非OA | Taylor and Francis Ltd |
| 191 | Journal of Mammary Gland Biology and Neoplasia | 0.76 | Q2 | 117 | 3.18 | United States | 非OA | Springer |
| 192 | Journal of Bionic Engineering | 0.76 | Q2 | 75 | 5.50 | China | 非OA | Springer |
| 193 | Nephron | 0.76 | Q2 | 106 | 2.49 | Switzerland | 非OA | S. Karger AG |
| 194 | Pharmacogenomics Journal | 0.76 | Q2 | 101 | 2.58 | United Kingdom | 非OA | Springer Nature |
| 195 | Applied Physiology, Nutrition and Metabolism | 0.76 | Q2 | 119 | 2.54 | Canada | 非OA | Canadian Science Publi |
| 196 | Biotechnology Journal | 0.76 | Q2 | 124 | 3.84 | Germany | 非OA | Wiley-VCH Verlag |
| 197 | Journal of Steroid Biochemistry and Molecular Biology | 0.76 | Q2 | 157 | 3.10 | United Kingdom | 非OA | Elsevier Ltd |
| 198 | Biochemical Engineering Journal | 0.75 | Q2 | 155 | 4.34 | Netherlands | 非OA | Elsevier B.V. |
| 199 | Frontiers in Bioscience - Scholar | 0.75 | Q2 | 64 | 2.82 | Hong Kong | 完全OA | IMR Press Limited |
| 200 | Functional and Integrative Genomics | 0.75 | Q2 | 94 | 4.10 | Germany | 非OA | — |